(Q52887374)

9 May 2018

title

[Treatment of children and adolescents with relapsed ALL: therapy target long-term healing]. (English)

1 reference

9 May 2018

1 reference

Arend von Stackelberg

series ordinal

3

object named as

Arend von Stackelberg

1 reference

9 May 2018

author name string

Gesche Tallen

series ordinal

1

1 reference

9 May 2018

Günter Henze

series ordinal

2

1 reference

9 May 2018

language of work or name

German

0 references

publication date

1 May 2012

1 reference

9 May 2018

Pharmazie in unserer Zeit

published in

1 reference

9 May 2018

volume

41

1 reference

9 May 2018

issue

3

1 reference

9 May 2018

page(s)

214-221

1 reference

9 May 2018

[Treatment of relapse in acute lymphoblastic leukaemia of childhood (author's transl)].

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPAUZ.201200470

Long-term outcome in children with relapsed acute lymphoblastic leukemia after time-point and site-of-relapse stratification and intensified short-course multidrug chemotherapy: results of trial ALL-REZ BFM 90.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPAUZ.201200470

Risk-adapted stratification and treatment of childhood acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPAUZ.201200470

Bone-marrow relapse in paediatric acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPAUZ.201200470

Relapse of TEL-AML1--positive acute lymphoblastic leukemia in childhood: a matched-pair analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPAUZ.201200470

Late relapses evolve from slow-responding subclones in t(12;21)-positive acute lymphoblastic leukemia: evidence for the persistence of a preleukemic clone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPAUZ.201200470

Very early/early relapses of acute lymphoblastic leukemia show unexpected changes of clonal markers and high heterogeneity in response to initial and relapse treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPAUZ.201200470

Relapse in childhood acute lymphoblastic leukemia is associated with a decrease of the Bax/Bcl-2 ratio and loss of spontaneous caspase-3 processing in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPAUZ.201200470

Expression of late cell cycle genes and an increased proliferative capacity characterize very early relapse of childhood acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPAUZ.201200470

Mutations and deletions of the TP53 gene predict nonresponse to treatment and poor outcome in first relapse of childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPAUZ.201200470

Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPAUZ.201200470

Outcome of children and adolescents with relapsed acute lymphoblastic leukaemia and non-response to salvage protocol therapy: a retrospective analysis of the ALL-REZ BFM Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPAUZ.201200470

Autologous bone-marrow transplants compared with chemotherapy for children with acute lymphoblastic leukaemia in a second remission: a matched-pair analysis. The Berlin-Frankfurt-Münster Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPAUZ.201200470

Outcome after first relapse in childhood acute lymphoblastic leukaemia - lessons from the United Kingdom R2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPAUZ.201200470

Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPAUZ.201200470

Allogeneic hematopoietic SCT in children with ALL: current concepts of ongoing prospective SCT trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPAUZ.201200470

Chemotherapy for bone marrow relapse of childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPAUZ.201200470

21 January 2018

Identifiers

DOI

10.1002/PAUZ.201200470

1 reference

9 May 2018

release_5fezgqwzgzb57h25hx72j5ipne

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5fezgqwzgzb57h25hx72j5ipne

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

9 May 2018